These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


378 related items for PubMed ID: 25743164

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Synthesis, characterization, conformational analysis of a cyclic conjugated octreotate peptide and biological evaluation of (99m)Tc-HYNIC-His(3)-Octreotate as novel tracer for the imaging of somatostatin receptor-positive tumors.
    Behera A, Banerjee I, De K, Munda RN, Chattopadhayay S, Samanta A, Sarkar B, Ganguly S, Misra M.
    Amino Acids; 2013 Mar; 44(3):933-46. PubMed ID: 23090293
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of [99mTc/EDDA/HYNIC0]octreotide derivatives compared with [111In-DOTA0,Tyr3, Thr8]octreotide and [111In-DTPA0]octreotide: does tumor or pancreas uptake correlate with the rate of internalization?
    Storch D, Béhé M, Walter MA, Chen J, Powell P, Mikolajczak R, Mäcke HR.
    J Nucl Med; 2005 Sep; 46(9):1561-9. PubMed ID: 16157541
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Tecnetium-99m as alternative to produce somatostatin-labeled derivatives: comparative biodistribution evaluation with 111In-DTPA-octreotide.
    Melo IB, Ueda LT, Araujo EB, Muramoto E, Barboz MF, Mengatti J, Buchpiguel CA, Silva CP.
    Cell Mol Biol (Noisy-le-grand); 2010 May 10; 56(2):31-6. PubMed ID: 20525456
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Technetium-99m somatostatin analogues: effect of labelling methods and peptide sequence.
    Decristoforo C, Mather SJ.
    Eur J Nucl Med; 1999 Aug 10; 26(8):869-76. PubMed ID: 10436200
    [Abstract] [Full Text] [Related]

  • 10. DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labelling with various radiometals.
    Wild D, Schmitt JS, Ginj M, Mäcke HR, Bernard BF, Krenning E, De Jong M, Wenger S, Reubi JC.
    Eur J Nucl Med Mol Imaging; 2003 Oct 10; 30(10):1338-47. PubMed ID: 12937948
    [Abstract] [Full Text] [Related]

  • 11. Preclinical evaluation of technetium-99m-labeled somatostatin receptor-binding peptides.
    Vallabhajosula S, Moyer BR, Lister-James J, McBride BJ, Lipszyc H, Lee H, Bastidas D, Dean RT.
    J Nucl Med; 1996 Jun 10; 37(6):1016-22. PubMed ID: 8683294
    [Abstract] [Full Text] [Related]

  • 12. Pre-clinical evaluation of a new indirectly labeled ⁹⁹mTc-6-hydrazinopyridine-3-carboxylic acid (HYNIC)-depreotide with HYNIC as bifunctional chelator.
    Yu F, Lü ML, Zhang XP, Fu D, Hou M, Cai HD, Li D, Wang J, Yuan XY, Lü ZW, Dong F.
    Chin Med J (Engl); 2012 Jul 10; 125(14):2538-42. PubMed ID: 22882936
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Radiopharmaceutical development of a freeze-dried kit formulation for the preparation of [99mTc-EDDA-HYNIC-D-Phe1, Tyr3]-octreotide, a somatostatin analog for tumor diagnosis.
    Guggenberg EV, Mikolajczak R, Janota B, Riccabona G, Decristoforo C.
    J Pharm Sci; 2004 Oct 10; 93(10):2497-506. PubMed ID: 15349959
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Synthesis, radiolabeling and evaluation of [99mTc][Tc-HYNIC/EDDA]-Met(O) as a early agent for amino acid metabolic imaging in C6 glioblastoma tumor.
    Dinmohammadi F, Erfani M, Shamsaei M, Shirmardi SP, Goudarzi M.
    Bioorg Chem; 2023 Jan 10; 130():106237. PubMed ID: 36402025
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.